Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Leukemia 22Lymphoma 14Leukemia, Myeloid, Acute 14Myelodysplastic Syndromes 12Leukemia, Lymphocytic, Chronic, B-Cell 12Breast Neoplasms 11Prostatic Neoplasms 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Multiple Myeloma 9Melanoma 9Lymphoma, Follicular 9Neuroblastoma 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Ovarian Neoplasms 7Congenital Abnormalities 7Lymphoma, Non-Hodgkin 6Hodgkin Disease 5Neoplasms, Plasma Cell 4Neoplasm Metastasis 4Myeloproliferative Disorders 4Lymphoma, Mantle-Cell 4Leukemia, Myeloid, Chronic-Phase 4Glioblastoma 4Fallopian Tube Neoplasms 4Anemia, Refractory, with Excess of Blasts 4Waldenstrom Macroglobulinemia 3Osteosarcoma 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell, Marginal Zone 3

Interventions

Doxorubicin 33Ifosfamide 23Gemcitabine 19pazopanib 18Cyclophosphamide 16Radiotherapy 15pembrolizumab 13Filgrastim 12Docetaxel 12Bevacizumab 10Vincristine 9Sirolimus 9Irinotecan 9Etoposide 9olaratumab 7eribulin 7Sorafenib 7Radiation 7temsirolimus 6Temozolomide 6Mesna 6Magnetic Resonance Spectroscopy 6Cisplatin 6tazemetostat 5cixutumumab 5Trabectedin 5Radiosurgery 5Nivolumab 5Ipilimumab 5Granulocyte Colony-Stimulating Factor 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Sarcoma × sargramostim × Clear all
NCT00066365 2015-03-30

Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma

Children's Oncology Group

Phase 2 Completed
49 enrolled 21 charts
Sarcoma

Neoplasm Metastasis, Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡